| Product Code: ETC6744755 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, China import of hemostatic agents saw steady growth with key suppliers including the USA, Finland, Germany, Hungary, and Japan. The market remained moderately concentrated with a manageable Herfindahl-Hirschman Index (HHI). The compound annual growth rate (CAGR) from 2020 to 2024 stood at a robust 8.87%, indicating a healthy demand for hemostatic agents in China. Furthermore, the growth rate in 2024 alone was a commendable 3.0%, reflecting continued momentum in the import market for hemostatic agents in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Hemostatic Agents Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 China Hemostatic Agents Market - Industry Life Cycle |
3.4 China Hemostatic Agents Market - Porter's Five Forces |
3.5 China Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing surgical procedures in China |
4.2.2 Growing prevalence of chronic diseases requiring hemostatic agents |
4.2.3 Technological advancements in hemostatic products |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for product approval |
4.3.2 High cost associated with advanced hemostatic agents |
4.3.3 Limited awareness among healthcare professionals and patients about hemostatic products |
5 China Hemostatic Agents Market Trends |
6 China Hemostatic Agents Market, By Types |
6.1 China Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 China Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 China Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 China Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 China Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 China Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 China Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 China Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 China Hemostatic Agents Market Import-Export Trade Statistics |
7.1 China Hemostatic Agents Market Export to Major Countries |
7.2 China Hemostatic Agents Market Imports from Major Countries |
8 China Hemostatic Agents Market Key Performance Indicators |
8.1 Adoption rate of advanced hemostatic agents in surgical procedures |
8.2 Rate of new product development and innovations in the hemostatic agents market |
8.3 Number of collaborations and partnerships between hemostatic agents manufacturers and healthcare institutions |
9 China Hemostatic Agents Market - Opportunity Assessment |
9.1 China Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Hemostatic Agents Market - Competitive Landscape |
10.1 China Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 China Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here